Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022254006 - CANNABIDIOL FOR USE IN THE TREATMENT OF PAIN RESULTING FROM AN INDOLEAMINE 2,3-DIOXYGENASE-1 (IDO1) RELATED DISEASE

Publication Number WO/2022/254006
Publication Date 08.12.2022
International Application No. PCT/EP2022/065185
International Filing Date 03.06.2022
IPC
A61K 31/05 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61P 29/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
02without antiinflammatory effect
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
CPC
A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 9/0014
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0014Skin, i.e. galenical aspects of topical compositions
A61K 9/0053
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0053Mouth and digestive tract, i.e. intraoral and peroral administration
A61P 29/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
02without antiinflammatory effect
Applicants
  • ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS [FR]/[FR]
Inventors
  • GRECO, Céline
  • KHOUKH, Karim
  • BRUNO, Fabien
Agents
  • GEVERS & ORES
Priority Data
21305752.404.06.2021EP
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CANNABIDIOL FOR USE IN THE TREATMENT OF PAIN RESULTING FROM AN INDOLEAMINE 2,3-DIOXYGENASE-1 (IDO1) RELATED DISEASE
(FR) CANNABIDIOL DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE LA DOULEUR RÉSULTANT D'UNE MALADIE ASSOCIÉE À L'INDOLÉAMINE 2,3-DIOXYGÉNASE-1 (IDO1)
Abstract
(EN) The present invention relates to cannabidiol (CBD), prodrugs thereof and pharmaceutically acceptable salts thereof, or a composition comprising such a compound, for use in the treatment or prevention of pain caused by an indoleamine 2,3-dioxygenase-1 (IDO1) related disease.
(FR) La présente invention concerne un cannabidiol (CBD), des promédicaments de celui-ci et des sels pharmaceutiquement acceptables de celui-ci, ou une composition comprenant un tel composé, à utiliser dans le traitement ou la prévention de la douleur provoquée par une maladie associée à l'indoléamine 2,3-dioxygénase-1 (IDO1).
Related patent documents
Latest bibliographic data on file with the International Bureau